Natural Solutions Foundation claimed on its website that Nano Silver could save Ebola victims, causing the U.S. Food And Drug Administration to issue a warning letter to the company. At the same time, the FDA issued warning letters to both Young Living and doTERRA ordering the removal of any unapproved health claims from marketing materials. The two essential oil companies quickly addressed and rectified the regulatory violation, but Natural Solutions announced that it is raising money for a legal fund to fight the FDA’s demands, according to an article on NASDAQ.
The FDA warning letter to Natural Solutions was slightly different from the warning letters sent to the essential oil manufacturers over health claims about Ebola “cures.” One difference between Nano Silver and essential oils is that Nano Silver does have FDA approval for some functions. The issue, according to the FDA, is that it is not approved as a cure or treatment for Ebola, yet it was being marketed as such.
“Furthermore, your products identified above are offered for conditions that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners; therefore, adequate directions for use cannot be written so that a layperson can use these drugs safely for their intended purposes.”
A video response to the warning letter about Nano Silver was uploaded to YouTube on September 28 and remains on YouTube as of October 3. Dr. Laibow and Natural Solutions say they are not backing down, as Inquisitr writer Terri LaPoint explained earlier this week.
According to the University of Michigan’s Risk Science, the research into Ebola presented by Janice Speshock and Saber Hussain at the U.S. Air Force National Laboratory that Natural Solutions allegedly referenced did show promise that Nano Silver could one day be a novel treatment for Ebola-like viruses, but a Risk Science analyst said that the Nano Silver and Ebola connection was more complicated than what Natural Solutions representatives are claiming.
“While it is impossible to interpret research findings from Powerpoint slides alone, the data do suggest that there are some unusual interactions between silver nanoparticles and Ebola-like viruses, although there are no data indicating whether similar interactions are also seen with other nanoparticles. More importantly, they do not indicate whether these same interactions would occur in an infected patient. They also do not indicate the quantity of silver nanoparticles someone wold need to take to render Ebola ineffective, or whether the necessary dose to have an effect would cause medical complications.”
In that same article, Risk Science did provide a video summary of benefits and risks of silver nano particles, their uses, and the history of silver nano particles.
The Wall Street Journal reported in August that Nigeria’s Minister of Health, Onyebuchi Chukwu, announced Nigeria would be using Nano Silver as an experimental drug to fight Ebola.
“Ebola victims in Nigeria’s commercial capital Lagos will receive an experimental drug called Nano Silver, the country’s top health official said on Thursday, in a step that introduces a new untested treatment to the fight against an outbreak in several West African countries.”
Given the severity of the Ebola crisis in West Africa, the World Health Organization (WHO) announced that the use of experimental drugs and medical intervention were actually warranted and would be investigated. WHO gathered a team to consider and assess the ethical implications of unregistered Ebola treatments.
After that, the FDA issued the warnings about false health claims regarding Ebola. The FDA has been clear that there are no approved or experimental treatments for Ebola available on the internet.
Within days of the initial announcement by Chukwu, he ended up announcing that the option for Nano Silver to be used by healthcare providers was rejected in Nigeria due to Nano Silver’s failure to pass approval by the National Health Research Committee. Reports stated that when put to the test, Nano Silver failed preliminary tests. He said that no Ebola patients were treated with Nano Silver while awaiting the approval.
“You will recall that last Thursday, I announced we were ready to deploy an experimental drug, Nano Silver, if it was cleared by the national health research committee,” Chuckwu stated to journalists, after learning of the results, according to Nigerian news source The Cable. “I regret to inform you that the drug did not meet the requirements of the national health research ethics code. Accordingly, approval for its use was withheld.”
Dr. Laibow was interviewed by an alternative news source where she explained more about the company’s feelings about Nano Silver and Ebola, discussed her concerns over what she claimed could be a government conspiracy, and actively promoted the Natural Solutions website. The video, which is in direct opposition to FDA regulation, made numerous references to the company’s website, prompting skeptics to challenge Dr. Laibow to just offer free Nano Silver to individuals in West Africa to prove her case instead of defending the company’s “commercial free speech.”
[Image via YouTube video]